Detalhe da pesquisa
1.
Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic model.
J Antimicrob Chemother
; 78(9): 2254-2262, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37527369
2.
Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistance.
J Antimicrob Chemother
; 78(12): 2869-2877, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37837411
3.
Comparative bactericidal activity of representative ß-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa.
J Antimicrob Chemother
; 77(5): 1306-1312, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35137096
4.
The effect of duration of therapy for treatment of Staphylococcus aureus blood stream infection: an application of cloning to deal with immortal-time bias in an analysis of data from a cohort study (BSI-FOO).
J Antimicrob Chemother
; 78(1): 196-204, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346710
5.
Trade-Offs between Antibacterial Resistance and Fitness Cost in the Production of Metallo-ß-Lactamases by Enteric Bacteria Manifest as Sporadic Emergence of Carbapenem Resistance in a Clinical Setting.
Antimicrob Agents Chemother
; 65(8): e0241220, 2021 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972250
6.
Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region.
J Antimicrob Chemother
; 76(12): 3144-3150, 2021 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34450630
7.
Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017-18.
J Antimicrob Chemother
; 75(1): 65-71, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31538190
8.
Methodological features of clinical pharmacokinetic-pharmacodynamic studies of antibacterials and antifungals: a systematic review.
J Antimicrob Chemother
; 75(6): 1374-1389, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32083674
9.
Antibacterial effect of imipenem/relebactam on aerobic Gram-negative bacilli: in vitro simulations of 7 or 14 day human exposures.
J Antimicrob Chemother
; 74(7): 1945-1951, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31220257
10.
Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE's STAT-Net.
Clin Infect Dis
; 67(12): 1922-1931, 2018 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30107400
11.
Prediction of Fluoroquinolone Susceptibility Directly from Whole-Genome Sequence Data by Using Liquid Chromatography-Tandem Mass Spectrometry To Identify Mutant Genotypes.
Antimicrob Agents Chemother
; 62(3)2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29263066
12.
Antibacterial effect of ceftolozane/tazobactam in combination with amikacin against aerobic Gram-negative bacilli studied in an in vitro pharmacokinetic model of infection.
J Antimicrob Chemother
; 73(9): 2411-2417, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30020472
13.
Pharmacodynamics of inhaled amikacin (BAY 41-6551) studied in an in vitro pharmacokinetic model of infection.
J Antimicrob Chemother
; 73(5): 1305-1313, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29562340
14.
Towards better antimicrobial susceptibility testing: impact of the Journal of Antimicrobial Chemotherapy.
J Antimicrob Chemother
; 72(2): 323-329, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28115501
15.
Pharmacodynamics of Ceftolozane plus Tazobactam Studied in an In Vitro Pharmacokinetic Model of Infection.
Antimicrob Agents Chemother
; 60(1): 515-21, 2016 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26552975
16.
A review of the pharmacokinetics and pharmacodynamics of aztreonam.
J Antimicrob Chemother
; 71(10): 2704-12, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27334663
17.
Differences in the pharmacodynamics of ceftaroline against different species of Enterobacteriaceae studied in an in vitro pharmacokinetic model of infection.
J Antimicrob Chemother
; 71(5): 1270-8, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26846209
18.
Early warning score: a dynamic marker of severity and prognosis in patients with Gram-negative bacteraemia and sepsis.
Ann Clin Microbiol Antimicrob
; 15: 23, 2016 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27071911
19.
Doxycycline in UK guidelines for hospital-acquired pneumonia: where is the evidence base?-authors' response.
J Antimicrob Chemother
; 74(6): 1767, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30915460
20.
Pharmacodynamics of ceftaroline against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.
Antimicrob Agents Chemother
; 57(6): 2451-6, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23459495